Month: August 2022

Aug 21 2022

Uncategorized

Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy

by Clinical Editor

No Comments

MapLight Therapeutics has concluded a Phase I clinical trial of ML-007 for treating neurologic ailments such as schizophrenia and dyskinesia.

Aug 21 2022

Uncategorized

Mattie’s Call: Man diagnosed with schizophrenia missing in South Fulton

by Clinical Editor

No Comments

A Mattie’s Call was issued on Friday for a missing man in South Fulton, authorities said. Curtis Bevly, who is 27 years old, was last seen in the 2500 block...

Aug 21 2022

Uncategorized

MAPLIGHT THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1 CLINICAL TRIAL FOR ML-007, A NOVEL THERAPY FOR THE TREATMENT OF SCHIZOPHRENIA AND DYSKINESIAS

by Clinical Editor

No Comments

MapLight Therapeutics today announced it has completed its Phase 1 clinical trial evaluating ML-007, the second clinical compound developed using the MapLight platform. ML-007 is an M1/M4 muscarinic …

Aug 21 2022

Uncategorized

Study Analyzes Schizophrenia and Dementia Link To Gauge Recovery Potential

by Clinical Editor

No Comments

New research has found similiarities between dementia and schizophrenia, examining a theory that is more than 120 years old and was previously questioned by the scientific community. The results …

Aug 20 2022

Uncategorized

Study Analyzes Schizophrenia and Dementia Link To Gauge Recovery Potential

by Clinical Editor

No Comments

One of the main differences between the two concepts is that the prognosis for dementia praecox is poor, while schizophrenia is considered a more positive diagnosis as many schizophrenic patients...

Aug 20 2022

Uncategorized

Schizophrenia and the College Years

by Clinical Editor

No Comments

Recognizing the first signs of a mental health disorder like schizophrenia is key to getting proper treatment. Unfortunately, most people aren’t trained to identify early warning cues. Symptoms like a...

Aug 20 2022

Uncategorized

Mattie’s Call: Man diagnosed with schizophrenia missing in South Fulton

by Clinical Editor

No Comments

A Mattie’s Call was issued on Friday for a missing man in South Fulton, authorities said. Curtis Bevly, who is 27 years old, was last seen in the 2500 block...

Aug 20 2022

Uncategorized

Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy

by Clinical Editor

No Comments

MapLight Therapeutics has concluded a Phase I clinical trial of ML-007 for treating neurologic ailments such as schizophrenia and dyskinesia.

Aug 20 2022

Uncategorized

Karuna CEO says he doesn’t expect company’s KarXT schizophrenia drug to lose its efficacy over time

by Clinical Editor

No Comments

CNBC’s Jim Cramer spoke with Karuna Therapeutics CEO Steve Paul on Wednesday’s episode of “Mad Money.” Got a confidential news tip? We want to hear from you. Sign up for...

Aug 19 2022

Uncategorized

Study Analyzes Schizophrenia and Dementia Link To Gauge Recovery Potential

by Clinical Editor

No Comments

One of the main differences between the two concepts is that the prognosis for dementia praecox is poor, while schizophrenia is considered a more positive diagnosis as many schizophrenic patients...